Carl Zeiss Meditec AG (CZMWF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
As of 09:30AM EDT. Market open.
| Previous close | 99.55 |
| Open | 99.55 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 99.55 - 99.55 |
| 52-week range | 81.00 - 133.53 |
| Volume | |
| Avg. volume | 48 |
| Market cap | 9.386B |
| Beta (5Y monthly) | 0.90 |
| PE ratio (TTM) | 29.98 |
| EPS (TTM) | 3.32 |
| Earnings date | 08 May 2024 |
| Forward dividend & yield | 1.19 (1.20%) |
| Ex-dividend date | 22 Mar 2024 |
| 1y target est | N/A |
Simply Wall St.Declining Stock and Solid Fundamentals: Is The Market Wrong About Carl Zeiss Meditec AG (ETR:AFX)?
It is hard to get excited after looking at Carl Zeiss Meditec's (ETR:AFX) recent performance, when its stock has...
- Simply Wall St.
What Does Carl Zeiss Meditec AG's (ETR:AFX) Share Price Indicate?
Carl Zeiss Meditec AG ( ETR:AFX ), might not be a large cap stock, but it received a lot of attention from a...
PR NewswireCarl Zeiss Meditec AG Completes Acquisition of Dutch Ophthalmic Research Center (D.O.R.C.); Companies Unite to Shape Ophthalmology Market
Carl Zeiss Meditec AG announced today that, after securing all required regulatory approvals, it has completed the acquisition of 100% of D.O.R.C. (Dutch Ophthalmic Research Center) from the investment firm Eurazeo SE, Paris, France. The acquisition enhances and complements ZEISS Medical Technology's broad ophthalmic portfolio and range of digitally connected workflow solutions for addressing a wide variety of eye conditions, spanning retina and cornea disorders, cataract, glaucoma, and refracti
© 2024 Yahoo. All rights reserved.